What Researchers Did
Researchers conducted a retrospective descriptive study collecting parent testimonials from 30 children and one adult with autism who received hyperbaric oxygen therapy (HBOT) between January 2020 and July 2023.
What They Found
The study collected parent testimonials from 31 individuals with autism who underwent HBOT, with four raters assessing progress on a 5-point Likert scale. Inter-rater reliability for these assessments was high (r = 0.831), indicating strong agreement among raters regarding observed impacts.
What This Means for Canadian Patients
This study, based on parent testimonials, suggests that some families perceive benefits from HBOT for autism symptoms. However, Canadian patients and their families should consult healthcare professionals for evidence-based treatments, as HBOT for autism is not widely recognized or funded in Canada.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
Limitations include the retrospective design, reliance on subjective parent testimonials, and a small sample size of 31 individuals.